Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Charles E. Buckler is active.

Publication


Featured researches published by Charles E. Buckler.


Proceedings of the National Academy of Sciences of the United States of America | 2003

Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: Implications for HIV-1 vaccine development

Yoshiaki Nishimura; Tatsuhiko Igarashi; Nancy L. Haigwood; Reza Sadjadpour; Olivia K. Donau; Charles E. Buckler; Ron Plishka; Alicia Buckler-White; Malcolm A. Martin

Passive transfer of high-titered antiviral neutralizing IgG, known to confer sterilizing immunity in pig-tailed monkeys, has been used to determine how soon after virus exposure neutralizing antibodies (NAbs) must be present to block a simian immunodeficiency virus (SIV)/HIV chimeric virus infection. Sterilizing protection was achieved in three of four macaques receiving neutralizing IgG 6 h after intravenous SIV/HIV chimeric virus inoculation as monitored by PCR analyses of and attempted virus isolations from plasma, peripheral blood mononuclear cell, and lymph node specimens. In the fourth animal, the production of progeny virus was suppressed for >4 weeks. A delay in transferring NAbs until 24 h after virus challenge resulted in infection in two of two monkeys. These results suggest that even if a vaccine capable of eliciting broadly reactive NAbs against primary HIV-1 were at hand, the Abs generated must remain at, or rapidly achieve, high levels within a relatively short period after exposure to virus to prevent the establishment of a primate lentivirus infection.


Science | 1963

Circulating Interferon in Mice after Intravenous Injection of Virus

Samuel Baron; Charles E. Buckler

Circulating interferon was detectable in mouse serum within 1 hour after the intravenous injection of various types of virus and it reached maximum levels in about 4 hours. Rapidly produced interferon may play a role in the pathogenesis of viral infection and in viral interference.


Journal of Virology | 2000

Short- and Long-Term Clinical Outcomes in Rhesus Monkeys Inoculated with a Highly Pathogenic Chimeric Simian/Human Immunodeficiency Virus

Yasuyuki Endo; Tatsuhiko Igarashi; Yoshiaki Nishimura; Charles E. Buckler; Alicia Buckler-White; Ronald J. Plishka; Dimiter S. Dimitrov; Malcolm A. Martin

ABSTRACT A highly pathogenic simian/human immunodeficiency virus (SHIV), SHIVDH12R, isolated from a rhesus macaque that had been treated with anti-human CD8 monoclonal antibody at the time of primary infection with the nonpathogenic, molecularly cloned SHIVDH12, induced marked and rapid CD4+ T cell loss in all rhesus macaques intravenously inoculated with 1.0 50% tissue culture infective dose (TCID50) to 4.1 × 105 TCID50s of virus. Animals inoculated with 650 TCID50s of SHIVDH12R or more experienced irreversible CD4+ T lymphocyte depletion and developed clinical disease requiring euthanasia between weeks 12 and 23 postinfection. In contrast, the CD4+ T-cell numbers in four of five monkeys receiving 25 TCID50s of SHIVDH12R or less stabilized at low levels, and these surviving animals produced antibodies capable of neutralizing SHIVDH12R. In the fifth monkey, no recovery from the CD4+ T cell decline occurred, and the animal had to be euthanized. Viral RNA levels, subsequent to the initial peak of infection but not at peak viremia, correlated with the virus inoculum size and the eventual clinical course. Both initial infection rate constants, k, and decay constants, d, were determined, but only the latter were statistically correlated to clinical outcome. The attenuating effects of reduced inoculum size were also observed when virus was inoculated by the mucosal route. Because the uncloned SHIVDH12R stock possessed the genetic properties of a lentivirus quasispecies, we were able to assess the evolution of the input virus swarm in animals surviving the acute infection by monitoring the emergence of neutralization escape viral variants.


Journal of Virology | 2007

Human Immunodeficiency Virus Type 1 Derivative with 7% Simian Immunodeficiency Virus Genetic Content Is Able To Establish Infections in Pig-Tailed Macaques

Tatsuhiko Igarashi; Ranjini Iyengar; Russel A. Byrum; Alicia Buckler-White; Robin L. Dewar; Charles E. Buckler; H. Clifford Lane; Kazuya Kamada; Akio Adachi; Malcolm A. Martin

ABSTRACT A human immunodeficiency virus type 1 (HIV-1) derivative (HIVNL-DT5R) containing sequences encoding a 7-amino-acid segment of CA and the entire vif gene from simian immunodeficiency virus (SIV) was previously shown to establish spreading infections in cultured macaque peripheral blood mononuclear cells. To assess its replicative and disease-inducing properties in vivo, HIVNL-DT5R was inoculated into pig-tailed macaques. HIVNL-DT5R generated plasma viremia in all five of the monkeys and elicited humoral responses against all of the HIV-1 structural proteins but did not cause CD4+ T-lymphocyte depletion or clinical disease. Additional adaptation will be required to optimize infectivity in vivo.


Experimental Biology and Medicine | 1972

Improved Assays for a Variety of Interferons

Herbert K. Oie; Charles E. Buckler; Carol P. Uhlendorf; David A. Hill; Samuel Baron

Summary Improved assays for a variety of interferons, based on the inhibition of yield of viral hemagglutinin, have been developed. These assays are advantageous because they combine the characteristics of rapidity, simplicity, reliability, sensitivity and inhibition of viral multiplication during a single cycle of growth. Since Sindbis virus produces hemagglutinin in a wide variety of animal cells, it is applicable for comparative interferon studies.


Journal of Virology | 2007

Loss of naïve cells accompanies memory CD4+ T-cell depletion during long-term progression to AIDS in Simian immunodeficiency virus-infected macaques.

Yoshiaki Nishimura; Tatsuhiko Igarashi; Alicia Buckler-White; Charles E. Buckler; Hiromi Imamichi; Robert Goeken; Wendy R. Lee; Bernard A. P. Lafont; Russ Byrum; H. Clifford Lane; Vanessa M. Hirsch; Malcolm A. Martin

ABSTRACT Human immunodeficiency virus and simian immunodeficiency virus (SIV) induce a slow progressive disease, characterized by the massive loss of memory CD4+ T cells during the acute infection followed by a recovery phase in which virus replication is partially controlled. However, because the initial injury is so severe and virus production persists, the immune system eventually collapses and a symptomatic fatal disease invariably occurs. We have assessed CD4+ T-cell dynamics and disease progression in 12 SIV-infected rhesus monkeys for nearly 2 years. Three macaques exhibiting a rapid progressor phenotype experienced rapid and irreversible loss of memory, but not naïve, CD4+ T lymphocytes from peripheral blood and secondary lymphoid tissues and died within the first 6 months of virus inoculation. In contrast, SIV-infected conventional progressor animals sustained marked but incomplete depletions of memory CD4+ T cells and continuous activation/proliferation of this T-lymphocyte subset. This was associated with a profound loss of naïve CD4+ T cells from peripheral blood and secondary lymphoid tissues, which declined at rates that correlated with disease progression. These data suggest that the persistent loss of memory CD4+T cells, which are being eliminated by direct virus killing and activation-induced cell death, requires the continuous differentiation of naïve into memory CD4+ T cells. This unrelenting replenishment process eventually leads to the exhaustion of the naïve CD4+T-cell pool and the development of disease.


Journal of Virology | 2002

Rapid and Irreversible CD4+ T-Cell Depletion Induced by the Highly Pathogenic Simian/Human Immunodeficiency Virus SHIVDH12R Is Systemic and Synchronous

Tatsuhiko Igarashi; Charles R. Brown; Russell Byrum; Yoshiaki Nishimura; Yasuyuki Endo; Ronald J. Plishka; Charles E. Buckler; Alicia Buckler-White; Georgina Miller; Vanessa M. Hirsch; Malcolm A. Martin

ABSTRACT Highly pathogenic simian/human immunodeficiency virus chimeric viruses are known to induce a rapid, irreversible depletion of CD4+ T lymphocytes in the peripheral blood of acutely infected macaque monkeys. To more fully assess the systemic effects of this primary virus infection, specimens were collected serially between days 3 and 21 postinfection from variety of lymphoid tissues (lymph nodes, thymus, and spleen) and gastrointestinal tract and examined by DNA and RNA PCR, in situ hybridization, and immunohistochemical assays. In addition, the lymphoid tissues were evaluated by fluorescence-activated cell sorting. Virus infection was initially detected by DNA PCR on day 3 postinfection in lymph node samples and peaked on day 10 in the T-lymphocyte-rich areas of this tissue. CD4+ T-cell levels remained stable through day 10 in several lymphoid tissue specimens examined but fell precipitously between days 10 and 21. In situ terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) assays revealed the accumulation of apoptotic cells during the second week of infection in both lymph nodes and thymus, which colocalized, to a large extent, to sites of both virus replication and CD4+ T-lymphocyte loss.


Mammalian Genome | 1998

Molecular phylogeny of Fv1

Chen-Feng Qi; François Bonhomme; Alicia Buckler-White; Charles E. Buckler; Annie Orth; Marilyn R. Lander; Sisir K. Chattopadhyay; Herbert C. Morse

Abstract. Alleles at the Fv1 gene of inbred mice confer resistance to infection and spread of vertically or horizontally transmitted murine leukemia viruses (MuLV). The nucleotide sequence of Fv1 bears similarity to the gag of a human endogenous retrovirus, HERV-L, but is more closely related to the gag-coding sequence of a newly described class of HERV-L-related mouse endogenous retroviruses designated MuERV-L. Both observations suggest an origin of Fv1 from endogenous gag sequences. The molecular definition of Fv1 provided an opportunity to determine the phylogeny of the gene among wild mice and its relation to MuERV-L. PCR primers, chosen to include most of the coding region of Fv1 for both the n and b alleles, were used to amplify sequences from animals of the genus Mus, which were then sequenced. Closely related products were obtained from almost all animals examined that evolved after the separation from Rattus, in which the homologous gene was shown to be absent. A phylogenetic tree generated with Fv1 sequence data differs noticeably from that developed with sequence data from other genes. In addition, non-synonymous changes were found to be present twice as frequently as synonymous changes, a fact that departs from the standard behavior of a structural gene. These observations suggest that the Fv1 gene may have been subjected to possible horizontal transfers as well as to positive Darwinian selection.


Journal of Virology | 2003

Macrophage-Tropic Simian/Human Immunodeficiency Virus Chimeras Use CXCR4, Not CCR5, for Infections of Rhesus Macaque Peripheral Blood Mononuclear Cells and Alveolar Macrophages

Tatsuhiko Igarashi; Olivia K. Donau; Hiromi Imamichi; Marie-Jeanne Dumaurier; Reza Sadjadpour; Ronald J. Plishka; Alicia Buckler-White; Charles E. Buckler; H. Clifford Lane; John P. Moore; Malcolm A. Martin

ABSTRACT After the nearly complete and irreversible depletion of CD4+ T lymphocytes induced by highly pathogenic simian/human immunodeficiency virus chimeric viruses (SHIVs) during infections of rhesus monkeys, tissue macrophages are able to sustain high levels (>106 viral RNA copies/ml) of plasma viremia for several months. We recently reported that the virus present in the plasma during the late macrophage phase of infection had acquired changes that specifically targeted the V2 region of gp120 (H. Imamichi et al., Proc. Natl. Acad. Sci. USA 99:13813-13818, 2002); some of these SHIV variants were macrophage-tropic (M-tropic). Those findings have been extended by examining the tropic properties, coreceptor usage, and gp120 structure of five independent SHIVs recovered directly from lymph nodes of late-stage animals. All of these tissue-derived SHIV isolates were able to infect alveolar macrophages. These M-tropic SHIVs used CXCR4, not CCR5, for infections of rhesus monkey PBMC and primary alveolar macrophages. Because the starting highly pathogenic T-tropic SHIV inoculum also utilized CXCR4, these results indicate that the acquisition of M-tropism in the SHIV-macaque system is not accompanied by a change in coreceptor usage. Compared to the initial T-tropic SHIV inoculum, tissue-derived M-tropic SHIVs from individual infected animals carry gp120s containing similar changes (specific amino acid deletions, substitutions, and loss of N-linked glycosylation sites), primarily within the V1 and/or V2 regions of gp120.


Experimental Biology and Medicine | 1969

Induction of the interferon mechanism by single-stranded RNA: potentiation by polybasic substances

Alfons Billiau; Charles E. Buckler; F Dianzani; Carol P. Uhlendorf; Samuel Baron

Summary A study was undertaken to determine whether the interferon-stimulating capacity of single-stranded RNA could be enhanced by substances which are known to combine with RNA, to enhance uptake of RNA into cells and to inhibit degradation of RNA by ribonuclease. The results demonstrated that the polybasic substances diethylaminoethyl-dextran (DEAE-dextran), methylated albumin, neomycin, streptomycin, and protamine sulfate markedly enhanced the induction of the interferon mechanism by single-stranded and by double-stranded synthetic RNAs. The demonstration that all the synthetic single-stranded preparations of polyinosinic acid and polycytidylic acid induced the interferon mechanism in the presence of the polybasic substances is strong evidence against the hypothesis that only double-stranded RNA is capable of inducing the interferon mechanism. In addition to the theoretical implications the present findings point to the possibility that the polybasic substances may be useful to enhance the antiviral action of RNAs for the control of viral infections. The authors acknowledge the technical assistance of Miss Carol Millikan and Miss Sharon Brandon.

Collaboration


Dive into the Charles E. Buckler's collaboration.

Top Co-Authors

Avatar

Samuel Baron

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Malcolm A. Martin

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Alicia Buckler-White

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert M. Friedman

Uniformed Services University of the Health Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Olivia K. Donau

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Bernard A. P. Lafont

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

M. L. Johnson

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge